Financials
Financial year 2025
Apotheek Waelput from Sint-Niklaas, company number BE0448997657, closed financial year 2025 with a result of € 226,873 after tax. For that financial year Apotheek Waelput recorded a gross margin of € 643,461 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 169,172 to € 226,873. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 15, 2026.
€ 1.1 million
▲ 25% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 226,873
▲ 34% vs 2024
Profit after tax over the fiscal year.
€ 177,617
▲ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.1 million.
People and assets in 2025
5.8
▲ 1.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 303,751
▲ 62% vs 2024
€ 52,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 29,083
▼ 3% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 77,802
▼ 47% vs 2024
€ 59,053 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 691,094
▲ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 129,394
▲ 48% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 346,108 | € 402,217 | € 418,193 | € 643,461 | ▲ 54% |
| Profit after taxes | € 100,833 | € 114,966 | € 169,172 | € 226,873 | ▲ 34% |
| Equity | € 635,925 | € 750,891 | € 920,064 | € 1,146,937 | ▲ 25% |
| Total debts | € 860,206 | € 893,345 | € 821,583 | € 912,628 | ▲ 11% |
| Cash | € 39,146 | € 126,901 | € 170,187 | € 177,617 | ▲ 4% |
| Retained profit | € 574,425 | € 689,391 | € 858,564 | € 1,085,437 | ▲ 26% |
| Bank debt | € 246,873 | € 203,463 | € 146,316 | € 77,802 | ▼ 47% |
| Balance sheet total | € 1,496,131 | € 1,644,237 | € 1,741,647 | € 2,059,565 | ▲ 18% |
| Employees (FTE) | 4.8 | 4.2 | 4.2 | 5.8 | ▲ 1.6 |
Key figures of Apotheek Waelput, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek Waelput?
What happened at Apotheek Waelput in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 226,873 (▲ 34% vs 2024). filed late Source: NBB ↗
- Bart Waelput became a director. NBB
- New establishment in Sint-Niklaas. KBO
- Start of the company according to the CBE. KBO
In short
From € 100,833 profit in 2022 to € 226,873 profit in 2025.
Paid € 288,537 in corporate taxes since 2022.
Best year ever: 2025, with € 226,873 profit.
On average € 110,900 of value added per employee in 2025.
Management
Behind Apotheek Waelput is Bart Waelput. It owns 20% of Farma Bovan and 10% of Pharma Solutions itself.
Directors
According to the 2025 annual accounts
since 2023
Establishments
Establishment units
Physical locations of this company
Nieuwkerkenstraat 111
9100 Sint-Niklaas
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Website info
Features
Details
- Company number
- 0448.997.657
- VAT number
- BE 0448.997.657
- Registered office
- Nieuwkerkenstraat 111, 9100 Sint-Niklaas
- Names & denominations
- Apotheek Waelput
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 1992
- Peppol
- Active · Active since 23 Dec 2025
- Contact
- apothekenwaelput.be
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten